Expand SPRO Menu
SPRO MENU

SPRO Stock Posts


Upcoming Earnings

SPRO Spero Therapeutics1.24+0.01 (+0.8%)

Spero Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±8.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±8.5%. View Expected Move (Conf Call: Aug 12 5:00 PM)
Unusual Option Volume

SPRO Spero Therapeutics1.69-0.49 (-22.5%)

Spero Therapeutics trades 2,596 contracts. News: Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties
View Details...
Unusual Option Volume

SPRO Spero Therapeutics2.21+0.10 (+4.7%)

Spero Therapeutics trades 2,657 contracts. News: Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
View Details...
Unusual Option Volume

SPRO Spero Therapeutics2.64-0.13 (-4.7%)

Spero Therapeutics trades 2,407 contracts.
View Details...
Upcoming Earnings

SPRO Spero Therapeutics2.55+0.01 (+0.4%)

Spero Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±6.2% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.7%. View Expected Move
Upcoming Earnings

SPRO Spero Therapeutics2.39-0.02 (-0.8%)

Spero Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±10.9% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±9.0%. View Expected Move
Load Earlier Posts
Market Data Delayed 15 Minutes